Department of Anaesthesia, Akershus University Hospital, Lørenskog, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Scand J Pain. 2021 May 10;21(4):680-687. doi: 10.1515/sjpain-2020-0176. Print 2021 Oct 26.
Labour is one of the most painful experiences in a woman's life. Epidural analgesia using low-concentration local anaesthetics and lipophilic opioids is the gold standard for pain relief during labour. Pregnancy in general, particularly labour, is associated with changes in maternal haemodynamic variables, such as cardiac output and heart rate, which increase and peak during uterine contractions. Adrenaline is added to labour epidural solutions to enhance efficacy by stimulating the α2-adrenoreceptor. The minimal effective concentration of adrenaline was found to be 2 μg mL for postoperative analgesia. The addition of adrenaline may also produce vasoconstriction, limiting the absorption of fentanyl into the systemic circulation, thereby reducing foetal exposure. However, adrenaline may influence the haemodynamic fluctuations, possibly adding to the strain on the circulatory system. The aim of this study was to compare the haemodynamic changes after application of labour epidural analgesia with or without adrenaline 2 μg mL.
This was a secondary analysis of a single-centre, randomised double-blind trial. Forty-one nulliparous women in labour requesting epidural analgesia were randomised to receive epidural solution of bupivacaine 1 mg mL, fentanyl 2 μg mL with or without adrenaline 2 μg mL. The participants were monitored using a Nexfin CC continuous non-invasive blood pressure and cardiac output monitor. The primary outcomes were changes in peak systolic blood pressure and cardiac output during uterine contraction within 30 min after epidural activation. The effect of adrenaline was tested statistically using a linear mixed-effects model of the outcome variables' dependency on time, adrenaline, and their interaction.
After excluding three patients due to poor data quality and two due to a malfunctioning epidural catheter, 36 patients (18 in each group) were analysed. The addition of adrenaline to the solution had no significant effect on the temporal changes in peak systolic blood pressure (p0.26), peak cardiac output (0.84), or heart rate (p0.91). Furthermore, no significant temporal changes in maternal haemodynamics (peak systolic blood pressure, p=0.54, peak cardiac output, p=0.59, or heart rate p=0.55) were associated with epidural analgesia during 30 min after epidural activation in both groups despite good analgesia.
The addition of 2 μg mL adrenaline to the epidural solution is not likely to change maternal haemodynamics during labour.
分娩是女性一生中最痛苦的经历之一。使用低浓度局部麻醉剂和脂溶性阿片类药物的硬膜外镇痛是分娩时缓解疼痛的金标准。一般来说,妊娠,特别是分娩,与产妇血液动力学变量的变化有关,如心输出量和心率,这些变量在子宫收缩期间增加并达到峰值。肾上腺素被添加到分娩硬膜外溶液中,通过刺激α2-肾上腺素受体来增强疗效。发现肾上腺素的最小有效浓度为 2μg/mL 用于术后镇痛。肾上腺素的添加也可能导致血管收缩,限制芬太尼进入体循环的吸收,从而减少胎儿暴露。然而,肾上腺素可能会影响血液动力学波动,可能会增加循环系统的负担。本研究的目的是比较应用含有或不含有 2μg/mL 肾上腺素的分娩硬膜外镇痛后的血液动力学变化。
这是一项单中心、随机双盲试验的二次分析。41 名要求硬膜外镇痛的初产妇被随机分为接受布比卡因 1mg/mL、芬太尼 2μg/mL 加或不加肾上腺素 2μg/mL 的硬膜外溶液。使用 Nexfin CC 连续无创血压和心输出量监测仪监测参与者。主要结局是硬膜外激活后 30 分钟内子宫收缩期间收缩期血压峰值和心输出量的变化。使用依赖于时间、肾上腺素及其相互作用的结果变量的线性混合效应模型对肾上腺素的作用进行统计学检验。
由于数据质量差排除了 3 名患者,由于硬膜外导管故障排除了 2 名患者,最终分析了 36 名患者(每组 18 名)。在溶液中添加肾上腺素对收缩期血压峰值(p0.26)、峰值心输出量(0.84)或心率(p0.91)的时间变化没有显著影响。此外,两组在硬膜外激活后 30 分钟内,尽管镇痛效果良好,但母体血液动力学(收缩期血压峰值,p=0.54,峰值心输出量,p=0.59,或心率 p=0.55)没有与硬膜外镇痛相关的显著时间变化。
在分娩期间,硬膜外溶液中添加 2μg/mL 肾上腺素不太可能改变产妇的血液动力学。